Sexually Transmitted DiseasesNCT06429683
Effectıveness of The Sexually Transmıtted Dıseases Educatıon Program for Adolescents
A study testing Sexually transmitted diseases training for young adolescents aged 17-21 in people with Sexually Transmitted Diseases, run by Bahar Nur Kanbur at 1 site in Turkey (Türkiye).
Trial summary
The World Health Organization has defined the period between the ages of 10-19 as adolescence, 15-24 years as youth and 10-24 years as youth period. Adolescence is divided into 3 periods: early adolescence (10-13 years), middle adolescence (14-16 years) and late adolescence (17-21 years). Read more about this study
- Who is it for?
- Ages 17 to 21 yearsHealthy volunteers can take part
- Conditions the study is for
- Sexually Transmitted Diseases
- What is being tested?
- Sexually transmitted diseases training for young adolescents aged 17-21
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 250 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2022to 1 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 to 21 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- At a Foundation University located within the borders of Istanbul Province 1.2.3. and 4th grade students
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
The World Health Organization has defined the period between the ages of 10-19 as adolescence, 15-24 years as youth and 10-24 years as youth period. Adolescence is divided into 3 periods: early adolescence (10-13 years), middle adolescence (14-16 years) and late adolescence (17-21 years). HIV virus and AIDS, which have become a problem among sexually transmitted diseases all over the world, have increased the importance of controlling sexually transmitted diseases. There is a strong correlation between the spread of STDs through traditional means and the transmission of HIV; and sexually transmitted diseases have been found to increase the risk of sexual transmission of HIV. According to WHO data, 340 million treatable STDs, millions of incurable STDs and 5 million HIV cases occur worldwide each year.
Read the detailed description
People in the 15-49 age group who are sexually active are the most likely to contract sexually transmitted diseases. The prevalence of STDs is higher in developing countries than in developed countries. These diseases are among the top 5 etiologic factors that cause loss of years of "healthy productive life" in developing countries. As in other countries, sexually transmitted diseases are of great importance in terms of complications and sequelae in Turkey
One out of 20 young people is infected with STDs every year. In our country, the age of sexual maturation has shifted earlier. In addition, the age of sexual experience of young people has also shifted earlier. Young people's understanding of freedom and their inability to access FP methods whenever they want negatively affect their sexual health behaviors. Impact on Society STDs cause a lot of economic and social damage to society. STDs may disrupt the normal functioning of family, community and health institutions and leave these institutions under a heavy economic burden. STDs reduce the productivity of men and women at the most productive ages of their lives. In addition, when outbreaks of these infections are not controlled, the costs to society will increase.
Translated with DeepL.com (free version)
- Conditions
- Sexually Transmitted Diseases
- Being tested
- Sexually transmitted diseases training for young adolescents aged 17-21
- Keywords
- adolescent, sexually transmitted diseases, education
- Medical subject headings
- Sexually Transmitted Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sexually transmitted diseases training for young adolescents aged 17-21Other
Education
| Study group | Role | What they receive |
|---|---|---|
| Sexually transmitted diseases training for young adolescents aged 17-21 | Experimental | To evaluate the effectiveness of sexually transmitted diseases education given to young adolescents aged 17-21 years Receives: Other: Sexually transmitted diseases training for young adolescents aged 17-21 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Students' Knowledge Test on Sexually Transmitted Diseases
The Sexually Transmitted Diseases Knowledge Test includes 36 questions that assess students' level of knowledge about sexually transmitted diseases. The questions are answered as "True", "False", and "I don't know". Students will be administered the STD knowledge test before the training. The test will be administered again after the training. In the post-training test, the student is expected to give more correct answers to the questions compared to the previous test.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 May 2024
- Study start1 Oct 2022
- Primary completion1 Feb 2023
- Study completion1 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sexually Transmitted DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 250 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bahar Nur Kanbur
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Bahar Nur Kanbur, Istanbul Gelisim University
- Investigators
- Canan Örüklü, Principal investigator, Trakya University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06429683
- Sponsor's protocol ID
- IstanbulGelisimuniversity
- Status last verified
- May 2024
- First submitted
- 17 May 2024
- Last updated
- 28 May 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectıveness of The Sexually Transmıtted Dıseases Educatıon Program for Adolescents
- ClinicalTrials.gov ID
- NCT06429683
- Acronym / sponsor ID
- IstanbulGelisimuniversity
- Conditions
- Sexually Transmitted Diseases
- Keywords
- adolescent, sexually transmitted diseases, education
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 250 participants (actual)
- Lead sponsor
- Bahar Nur KanburUniversity, hospital or other
- Study start
- 1 Oct 2022 (actual)
- Primary completion
- 1 Feb 2023 (actual)
- Study completion
- 1 Jun 2023 (actual)
- First posted
- 28 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The World Health Organization has defined the period between the ages of 10-19 as adolescence, 15-24 years as youth and 10-24 years as youth period. Adolescence is divided into 3 periods: early adolescence (10-13 years), middle adolescence (14-16 years) and late adolescence (17-21 years). HIV virus and AIDS, which have become a problem among sexually transmitted diseases all over the world, have increased the importance of controlling sexually transmitted diseases. There is a strong correlation between the spread of STDs through traditional means and the transmission of HIV; and sexually transmitted diseases have been found to increase the risk of sexual transmission of HIV. According to WHO data, 340 million treatable STDs, millions of incurable STDs and 5 million HIV cases occur worldwide each year.
Detailed description
People in the 15-49 age group who are sexually active are the most likely to contract sexually transmitted diseases. The prevalence of STDs is higher in developing countries than in developed countries. These diseases are among the top 5 etiologic factors that cause loss of years of "healthy productive life" in developing countries. As in other countries, sexually transmitted diseases are of great importance in terms of complications and sequelae in Turkey
One out of 20 young people is infected with STDs every year. In our country, the age of sexual maturation has shifted earlier. In addition, the age of sexual experience of young people has also shifted earlier. Young people's understanding of freedom and their inability to access FP methods whenever they want negatively affect their sexual health behaviors. Impact on Society STDs cause a lot of economic and social damage to society. STDs may disrupt the normal functioning of family, community and health institutions and leave these institutions under a heavy economic burden. STDs reduce the productivity of men and women at the most productive ages of their lives. In addition, when outbreaks of these infections are not controlled, the costs to society will increase.
Translated with DeepL.com (free version)
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Sexually transmitted diseases training for young adolescents aged 17-21 | Experimental | Other: Sexually transmitted diseases training for young adolescents aged 17-21To evaluate the effectiveness of sexually transmitted diseases education given to young adolescents aged 17-21 years |
Who may qualify
- Ages
- 17 to 21 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- At a Foundation University located within the borders of Istanbul Province 1.2.3. and 4th grade students
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sexually transmitted diseases training for young adolescents aged 17-21Education | Other | Sexually transmitted diseases training for young adolescents aged 17-21 |
Primary outcome
Students' Knowledge Test on Sexually Transmitted Diseases
Time frame: 2 months
The Sexually Transmitted Diseases Knowledge Test includes 36 questions that assess students' level of knowledge about sexually transmitted diseases. The questions are answered as "True", "False", and "I don't know". Students will be administered the STD knowledge test before the training. The test will be administered again after the training. In the post-training test, the student is expected to give more correct answers to the questions compared to the previous test.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 May 2024.
- Individual participant dataSharing planned: No
Related trials for Sexually Transmitted Diseases
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruitingPhase 1/2
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
Human Papillomavirus Infection
Active, not recruitingPhase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Enrolling by invitation
Promoting Aging and Thriving With HIV
HIV (Human Immunodeficiency Virus), Geriatric
RecruitingObservational study
Cohort of Women Living With HIV-1 and Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide
HIV (Human Immunodeficiency Virus), Pregnancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Canan Örüklü principal investigator
Trakya University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sexually transmitted diseases training for young adolescents aged 17-21 in people with Sexually Transmitted Diseases, run by Bahar Nur Kanbur at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Students' Knowledge Test on Sexually Transmitted Diseases (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2024.